Our capabilities

Coordinated support across the pharmaceutical market-entry pathway

From initial opportunity assessment to launch and supply coordination, our scope is defined by the product, market, regulatory pathway and responsibilities of each party.

01

Pharmaceutical market-entry consultancy

Opportunity assessment, market evaluation, entry-route planning and commercial feasibility for selected UAE and MENA opportunities.

02

Regulatory coordination

Document-gap assessment, registration planning, submission coordination, variation support, labelling review and communication with qualified local regulatory stakeholders.

03

Pharmaceutical trading

Licensed import, export and re-export coordination according to applicable authorisations and product-specific regulatory requirements.

04

Commercial representation & business development

Manufacturer introductions, distributor identification, portfolio positioning, negotiation support and partnership coordination.

05

Tender & institutional market support

Opportunity monitoring, product assessment, bid coordination and pricing intelligence. Tender awards cannot be promised.

06

Supply-chain & logistics coordination

Shipment planning and import-document coordination with appropriately licensed logistics, customs and third-party warehousing providers.

07

Packaging & labelling support

Artwork coordination, market-specific labelling assessment and communication between manufacturers and local stakeholders.

08

Pharmaceutical studies & research

Market research, portfolio evaluation, competitor analysis and strategic commercial assessments.

Scope note

Every service is subject to the applicable product classification, authority requirements, contractual scope and availability of appropriately licensed parties. Pinnacle does not promise regulatory approval, tender awards, appointments, exclusivity, delivery timelines or commercial outcomes.